Open tender · Germany · Pharmaceutical products
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Rivaroxaban (ATC-Code: B01AF01 - in allen Wirkstärken außer 2,5 mg je abgeteilte orale Darreichungsform)
In EnglishConclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for pharmaceutical products with the active substance Rivaroxaban (ATC code: B01AF01 - in all strengths except 2.5 mg per unit oral dosage form)
AOK Niedersachsen. Die Gesundheitskasse.
AOK Niedersachsen. Die Gesundheitskasse. in Germany is inviting bids for “Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for pharmaceutical products with the active substance Rivaroxaban…”. Bids close on 27 June 2028, 12:00 GMT+1. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Conclusion of a non-exclusive discount contract for the drug Rivaroxaban for the period 01.09.2026 to 31.08.2028 via an open-house model.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 4 requirements to qualify (2 on experience, 1 certifications and registrations, 1 policy conditions) and the 1 document a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences